VLA4-Targeted Nanoparticles Hijack Cell Adhesion–Mediated Drug Resistance to Target Refractory Myeloma Cells and Prolong Survival

Francesca Fontana(University of Trento), Gregory M. Lanza(Washington University in St. Louis)
Clinical Cancer Research
December 22, 2020
Cited by 27


Related Papers